ArticleJournal of medical biochemistry2018

Clinical Utility of Survivin (BIRC5), Novel Cardiac Biomarker, as a Prognostic Tool Compared to High-sensitivity C-reactive Protein, Heart-type Fatty Acid Binding Protein and Revised Lee Score in Elderly Patients Scheduled for Major Non-cardiac Surgery: A Prospective Pilot Study.

Danica Marković et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.